{"podcast":{"title":"Stocks To Watch","slug":"stocks-to-watch-5696376","podcast_index_feed_id":5696376,"rss_url":"https://stockstowatch.podomatic.com/rss2.xml","website_url":"https://www.podomatic.com/podcasts/stockstowatch","image_url":"https://assets.podomatic.net/ts/7a/39/41/ziga10954/1400x1400_16741795.png","author":"Global One Media Pte. Ltd.","episode_count":826,"summary":"Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Jon Franklin, Kyle Livingston and Moneer Barazi, along with contributors, Don Durrett and John Feneck, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1","last_synced_at":"2026-07-01T06:18:32.689786+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376"},"episode":{"title":"Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics","slug":"episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics","published_at":"2026-05-27T15:14:51+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics","show_page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376","url":"https://www.podomatic.com/podcasts/stockstowatch/episodes/2026-05-27T08_14_51-07_00","audio_url":"https://pdcn.co/e/stockstowatch.podomatic.com/enclosure/2026-05-27T08_14_51-07_00.mp3?_=1779894894.17784777","summary":"This interview is disseminated on behalf of Conexeu Sciences Inc. Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration. Learn more: https://www.conexeu.com/ Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU And follow us to stay updated: https://www.youtube.com/GlobalOneMedia","meta_description":"This interview is disseminated on behalf of Conexeu Sciences Inc. Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the compa…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1518,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-822-conexeu-sciences-cnxu-the-future-of-regenerative-aesthetics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}